Cargando…
外周血检测指标联合TCF1(+)CD8(+) T淋巴细胞占比预测中晚期肺癌免疫治疗疗效及预后的临床队列研究
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) therapy lacks viable biomarkers for response and prognosis prediction. This study aimed to investigate the correlation of peripheral blood laboratory test results combined with lymphocyte subset ratios to the response and prognosis of imm...
Autores principales: | LUO, Hong, DAI, Sisi, LI, Yalun, TIAN, Panwen, LI, Qintong, CAI, Xuyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558764/ https://www.ncbi.nlm.nih.gov/pubmed/37752540 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.29 |
Ejemplares similares
-
外周血炎症指标作为预测性指标在晚期非小细胞肺癌免疫治疗中的应用
Publicado: (2021) -
肿瘤实性成分占比在早期周围型肺癌诊疗中的研究进展
Publicado: (2022) -
小细胞肺癌免疫治疗疗效预测指标的现状与未来
Publicado: (2020) -
外周血游离DNA的动态变化预测TKI治疗EGFR突变肺腺癌患者的疗效
Publicado: (2019) -
外周血造血干细胞采集对166名健康供者外周血细胞计数的近期影响
Publicado: (2015)